The Immune-based Prognostic Score for the Immunogenomic LandscapeAanalysis and Application of Chemotherapy in Breast Cancer

Qianzi Lu(Harbin Medical University), Lei Yang(Harbin Medical University), Dongqing Su(Harbin Medical University), Yu Yao(Qinghai University), Yuqiang Xiong(Harbin Medical University), Haodong Wei(Harbin Medical University), Shiyuan Wang(Hainan Medical University), Yi Pan(Harbin Medical University), Yongchun Zuo(Inner Mongolia University)
Current Bioinformatics
May 25, 2022
10.2174/1574893617666220524123825
Cited by 2

Related Papers

CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227